Search

Filters
Clear All
  • 7
  • 3

Phase

  • 1
  • 2
  • 1
  • 5
  • 1
  • 10

Found 10 cheri-west trials

A listing of cheri-west medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

L
Lisa Landrum, MD, PhD, MS
18 years or above
Female
Phase 3
Interventional
What is the purpose of this study?This is a Phase 3, multicenter, open-label, randomized study of nemvaleukin in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, …
S
Sharon E. Robertson
18 years or above
Female
Phase 2
Interventional
What is the purpose of this study?The purpose of this research study is to test the safety of Niraparib and dostarlimab as abination treatment and see what effects (good and bad) this combination treatment has onwith recurrent or progressive cervix cancer.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with …
L
Lisa Landrum, MD, PhD, MS
18 years or above
Female
Phase 2/3
Interventional
What is the purpose of this study?This phase II/III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin HylectaTM) or pertuzumab, trastuzumab and hyaluronidase-zzxf (PhesgoTM) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial serous carcinoma or carcinosarcoma. Trastuzumab and pertuzumab are monoclonal …
L
Lisa Landrum, MD, PhD, MS
18 years or above
All genders
Phase 3
Interventional
What is the purpose of this study?GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.THIS STUDY IS ENROLLING BY INVITATION …
J
Jessica Parker Metter
18 years - 100 years
Female
Phase 3
Interventional
What is the purpose of this study?The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer …
L
Lisa Landrum, MD, PhD, MS
18 years - 100 years
Female
Phase 3
What is this study about?This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectomy for stage I endometrial cancer. Standard lymph node dissection removes lymph nodes around the …
S
Sharon E. Robertson
18 years - 100 years
Female
Phase 2
What is the purpose of this study?The primary objective of this study is to investigate the safety of replacing inguinofemoral lymphadenectomy by chemoradiation in early stage vulvar cancer patients with a macrometastasis (>2mm) and/or extracapsular extension in the SN. The secondary objective is to evaluate the short and long-term morbidity …
J
Jessica Parker Metter
35 years - 50 years
Female
What is this study about?This study is investigating how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 1/2
What is the purpose of this study?This phase I trial studies the side effects and best dose of vaccine therapy in treating patients with metastatic solid tumors. Vaccines made from antibodies and peptides combined with tumor cells may help the body build an effective immune response to kill tumor cells.THIS …
J
Jessica Parker Metter
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme …